|

Quantitative MRI of Bone Marrow in Patients With Acute Lymphoblastic Leukemia

RECRUITINGN/ASponsored by Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Actively Recruiting
PhaseN/A
SponsorFederal Research Institute of Pediatric Hematology, Oncology and Immunology
Started2021-02-22
Est. completion2026-03-01
Eligibility
Age6 Years – 18 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT04767165

Summary

The study is aimed at assessing changes in the bone marrow of patients from 6 to 18 years old with a diagnosis of acute lymphoblastic leukemia during chemotherapy. Patients of the same age without hematological diseases will be recruited as a control group.

Eligibility

Age: 6 Years – 18 YearsHealthy volunteers accepted
Inclusion Criteria:

1. patients from 6 to 18 years old
2. diagnosis of acute lymphoblastic leukemia during chemotherapy
3. patients of the same age without hematological diseases

Exclusion Criteria:

1. patients less then 6, and older then 18 years old
2. patients who cannot perform the study MRI without general anesthesia

Conditions2

Acute LeukemiaCancer

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.